Search Header Logo
FDA Expands Pfizer COVID Booster, Opens Extra Dose To Age 16 And Up

FDA Expands Pfizer COVID Booster, Opens Extra Dose To Age 16 And Up

Assessment

Interactive Video

Health Sciences, Social Studies, Biology

University

Practice Problem

Hard

Created by

Wayground Content

FREE Resource

The FDA has extended emergency use authorization for Pfizer's COVID-19 booster to include 16 and 17-year-olds, following a study showing increased protection against the Omicron variant. Despite this, only 25% of the eligible U.S. population has received a booster. Experts emphasize the importance of boosters and masks, particularly N95s, in combating the variant. The World Health Organization warns Omicron could alter the pandemic's trajectory, and experts call for redefining 'fully vaccinated' to mean three doses.

Read more

5 questions

Show all answers

1.

OPEN ENDED QUESTION

3 mins • 1 pt

What concerns are growing regarding the Omicron variant?

Evaluate responses using AI:

OFF

2.

OPEN ENDED QUESTION

3 mins • 1 pt

What recent change did the FDA make regarding booster shots for teenagers?

Evaluate responses using AI:

OFF

3.

OPEN ENDED QUESTION

3 mins • 1 pt

What did the Pfizer study indicate about booster shots?

Evaluate responses using AI:

OFF

4.

OPEN ENDED QUESTION

3 mins • 1 pt

What is the significance of the 25% figure mentioned in relation to booster shots?

Evaluate responses using AI:

OFF

5.

OPEN ENDED QUESTION

3 mins • 1 pt

What recommendations did health experts make regarding mask usage?

Evaluate responses using AI:

OFF

Access all questions and much more by creating a free account

Create resources

Host any resource

Get auto-graded reports

Google

Continue with Google

Email

Continue with Email

Classlink

Continue with Classlink

Clever

Continue with Clever

or continue with

Microsoft

Microsoft

Apple

Apple

Others

Others

Already have an account?